Colossal founder Ben Lamm explains the company's scientific efforts to restore extinct bird species.
Accro Bioscience Inc. ("Accro Bioscience"), a clinical-stage biotechnology company pioneering the development of novel therapeutics that target molecular mechanisms of regulatory cell death for immune ...
"We expect to begin recording product revenue from DARE to PLAY in the third quarter of 2026" (Chief Accounting Officer Haring-Layton), while adding, "Flora Sync LF5 consumer health product revenue is ...
15h
Scientists call for stewardship practices to be integrated into biodiversity conservation frameworks
A new article in the journal BioScience argues that the stewardship practices of Indigenous Peoples and other place-based ...
Accro Bioscience raises $50M Series C to advance UC drug AC-101 and expand its immune disease clinical pipeline across global ...
Q2 FY26 earnings call highlights: raised revenue guide, AI-enabled drug discovery, AWS partnership, margin and EBITDA outlook.
TheWell Bioscience, a biotechnology company pioneering advanced 3D cell culture technologies, today announced the launch of its RocketCell™ Organoid Xeno-Free Essential-Core Medium, a chemically ...
Tru Niagen is expanding its patented nicotinamide riboside, known as Niagen, into skincare and beauty supplements. Driven by consumer demand, Niagen Bioscience’s leadership in N ...
The name BioHeartland was created to give Indiana “a more cohesive and unified way to share the state’s story with investors, ...
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today expanded its clonal genes portfolio with the early access launch of Complex Genes.
View Twist Bioscience Corp. TWST stock quote prices, financial information, real-time forecasts, and company news from CNN.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results